Longitudinal Study of Body Composition of 101 HIV Men With Lipodystrophy: Dual-Energy X-Ray Criteria for Lipodystrophy Evolution

被引:18
作者
Degris, Emilie [1 ]
Delpierre, Cyrille [2 ]
Sommet, Agnes [3 ]
Sire, Stephane
Lassoued, Slim
Aquilina, Christian [4 ]
Marchou, Bruno [5 ]
Massip, Patrice [5 ]
Obadia, Martine [5 ]
Marion-Latard, Fabrice [6 ]
Bonnet, Eric [5 ]
Bernard, Jacques [7 ]
机构
[1] Paule de Viguier Hosp, Unit Pharm, Toulouse, France
[2] INSERM, U558, F-31073 Toulouse, France
[3] Purpan Hosp, Clin Pharmacol Unit, Toulouse, France
[4] La Grave Hosp, Unit Dermatol, Toulouse, France
[5] Purpan Hosp, Unit Infect & Trop Dis, Toulouse, France
[6] Hop Rangueil, Unit Sport Med, Toulouse, France
[7] Hop Rangueil, Rheumatol Unit, Toulouse, France
关键词
Antiretroviral therapy; body composition; bone mineral density; DXA assessment; HIV-infected; BONE-MINERAL DENSITY; ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; METABOLIC ABNORMALITIES; PROTEASE INHIBITORS; THYMIDINE ANALOG; FAT DISTRIBUTION; TENOFOVIR DF; LIPOATROPHY; HAART;
D O I
10.1016/j.jocd.2009.12.004
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The aim of this study was to define evolution profiles of body composition among human immunodeficiency virus (HIV)-infected men with lipodystrophy. The design is a retrospective analysis using observational data collected longitudinally. We included 101 HIV-infected men with lipodystrophy managed in routine practice and who had 2 dual energy Xray absorptiometry scans within a minimum interval of 18 mo. Lipodystrophy was defined as a fat mass ratio (FMR, defined as the ratio of the percentage of the trunk fat mass over the percentage of the lower limbs fat mass) equal or superior to 1.5. Patients were classified in "improved" group (IG: increase of lower limbs fat mass >= 10%) or "nonimproved" group (NIG). Body composition, immunovirological and epidemiological data were collected and compared between the 2 groups. In the whole population, over a 4-yr period, a significant increase was observed for total fat mass, trunk fat mass, and lower limbs fat mass, whereas total lean mass was stable. Total body mineral density decreased. Fifty-nine patients (IG), less exposed to zidovudine than the NIG, had an increase of lower limbs fat mass higher than 10%. But only 13 (22%) regained a normal distribution of fat mass (FMR < 1.5), showing that lipodystrophy was slowly reversible. Among the NIG, 5 patients (11.9%), less exposed to zidovudine and with a higher mean of viral load, reached an FMR below 1.5. It was mainly because of a loss of trunk fat mass, which could be the sign of a lipodystrophy worsening. Lipodystrophy improved for 58.4% of men. The improvement was very slow. Recovery was observed only in patients with an earlier intervention. No correlation was observed between lipodystrophy and total body bone mineral density. The loss of trunk fat mass without gain of lower limbs fat mass may indicate a worsening of HIV disease.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 41 条
[1]
BMD is reduced in HIV-infected men irrespective of treatment [J].
Amiel, C ;
Ostertag, A ;
Slama, L ;
Baudoin, C ;
N'Guyen, T ;
Lajeunie, E ;
Neit-Ngeilh, L ;
Rozenbaum, W ;
De Vernejoul, MC .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (03) :402-409
[2]
Anostos K, 2007, ANTIVIR THER, V12, P1049
[3]
Fat distribution in men with HIV infection [J].
Bacchetti, P ;
Gripshover, B ;
Grunfeld, C ;
Heymsfield, S ;
McCreath, H ;
Osmond, D ;
Saag, M ;
Scherzer, R ;
Shlipak, M ;
Tien, P .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (02) :121-131
[4]
Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive [J].
Bergersen, BM ;
Sandvik, L ;
Ellingsen, I ;
Bruun, JN .
HIV MEDICINE, 2005, 6 (04) :260-267
[5]
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years [J].
Bolland, Mark J. ;
Grey, Andrew B. ;
Horne, Anne M. ;
Briggs, Simon E. ;
Thomas, Mark G. ;
Ellis-Pegler, Rod B. ;
Woodhouse, Andrew F. ;
Gamble, Greg D. ;
Reid, Ian R. .
CLINICAL ENDOCRINOLOGY, 2007, 67 (02) :270-275
[6]
Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy [J].
Bolland, Mark J. ;
Grey, Andrew B. ;
Horne, Anne M. ;
Briggs, Simon E. ;
Thomas, Mark G. ;
Ellis-Pegler, Rod B. ;
Woodhouse, Andrew F. ;
Gamble, Greg D. ;
Reid, Ian R. .
CLINICAL ENDOCRINOLOGY, 2006, 65 (02) :191-197
[7]
Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men -: Proposal of reference values for defining lipodystrophy [J].
Bonnet, E ;
Delpierre, C ;
Sommet, A ;
Marion-Latard, F ;
Hervé, R ;
Aquilina, C ;
Labau, E ;
Obadia, M ;
Marchou, B ;
Massip, R ;
Perret, B ;
Bernard, J .
JOURNAL OF CLINICAL DENSITOMETRY, 2005, 8 (03) :287-292
[8]
BONNET E, 2007, 9 INT WORKSH ADV DRU
[9]
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review [J].
Brown, Todd T. ;
Qaqish, Roula B. .
AIDS, 2006, 20 (17) :2165-2174
[10]
Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia [J].
Brown, TT ;
Ruppe, MD ;
Kassner, R ;
Kumar, P ;
Kehoe, T ;
Dobs, AS ;
Timpone, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) :1200-1206